Thank you for sharing!

Your article was successfully shared with the contacts you provided.

It’s fair to say that Sarah-Jane Chilver-Stainer is a high achiever. When she spoke to Treasury & Risk earlier this month, she had just completed a record-breaking dollar bond issue for GlaxoSmithKline, the London-based pharmaceutical and healthcare company. The $5 billion issue, which attracted $15 billion in demand, included three-, five- and 10-year notes with coupons of 0.75%, 1.5% and 2.85%, respectively—the lowest coupons ever achieved on U.S. dollar bonds sold by a UK company.

T&R Express

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.